HomeCompaniesProfile

Serinus Biosciences

Combinations therapy by rational design 


Company Size

6 - 10 employees

Year Founded

2022


About Serinus Biosciences

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

Founders & Key People

Maxwell Sherman

Maxwell Sherman

Founder/CTO, Serinus Biosciences

Adam Yaari

Adam Yaari

Founder/CEO, Serinus Biosciences

Share This Profile

More Companies

InsureMyTeam

Disrupting Indian Insurance space by empowering distrubutors

ShipBob

Providing Amazon level logistics to e-commerce businesses.

Edlyft

Helps enterprises train college CS students on essential job skills

Chowdeck

On-demand food delivery for Africa

Invopop

We help global software companies comply with local tax reporting

Playground AI

Make graphics like a Pro without being one

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.